Class information for:
Level 1: SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8711 1157 35.8 79%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1637 6442 SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SGLT2 INHIBITOR Author keyword 284 94% 9% 103
2 DAPAGLIFLOZIN Author keyword 253 92% 8% 98
3 CANAGLIFLOZIN Author keyword 164 89% 6% 74
4 SGLT2 Author keyword 160 86% 7% 81
5 EMPAGLIFLOZIN Author keyword 118 90% 4% 52
6 URINARY GLUCOSE EXCRETION Author keyword 62 92% 2% 24
7 IPRAGLIFLOZIN Author keyword 45 90% 2% 19
8 SGLT2 INHIBITORS Author keyword 44 77% 3% 30
9 SODIUM GLUCOSE CO TRANSPORTER 2 SGLT2 INHIBITOR Author keyword 41 100% 1% 15
10 SGLT Author keyword 25 51% 3% 35

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SGLT2 INHIBITOR 284 94% 9% 103 Search SGLT2+INHIBITOR Search SGLT2+INHIBITOR
2 DAPAGLIFLOZIN 253 92% 8% 98 Search DAPAGLIFLOZIN Search DAPAGLIFLOZIN
3 CANAGLIFLOZIN 164 89% 6% 74 Search CANAGLIFLOZIN Search CANAGLIFLOZIN
4 SGLT2 160 86% 7% 81 Search SGLT2 Search SGLT2
5 EMPAGLIFLOZIN 118 90% 4% 52 Search EMPAGLIFLOZIN Search EMPAGLIFLOZIN
6 URINARY GLUCOSE EXCRETION 62 92% 2% 24 Search URINARY+GLUCOSE+EXCRETION Search URINARY+GLUCOSE+EXCRETION
7 IPRAGLIFLOZIN 45 90% 2% 19 Search IPRAGLIFLOZIN Search IPRAGLIFLOZIN
8 SGLT2 INHIBITORS 44 77% 3% 30 Search SGLT2+INHIBITORS Search SGLT2+INHIBITORS
9 SODIUM GLUCOSE CO TRANSPORTER 2 SGLT2 INHIBITOR 41 100% 1% 15 Search SODIUM+GLUCOSE+CO+TRANSPORTER+2+SGLT2+INHIBITOR Search SODIUM+GLUCOSE+CO+TRANSPORTER+2+SGLT2+INHIBITOR
10 SGLT 25 51% 3% 35 Search SGLT Search SGLT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DAPAGLIFLOZIN 230 81% 12% 138
2 SGLT2 INHIBITOR 229 92% 8% 91
3 INADEQUATE GLYCEMIC CONTROL 161 70% 12% 135
4 NA GLUCOSE COTRANSPORTER 130 47% 18% 204
5 SELECTIVE SGLT2 INHIBITOR 118 90% 4% 52
6 COTRANSPORTER 2 INHIBITOR 106 95% 3% 36
7 T 1095 99 97% 3% 29
8 RENAL GLUCOSURIA 82 92% 3% 33
9 SGLT2 79 88% 3% 37
10 COTRANSPORTER SGLT2 72 93% 2% 27

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Pharmacodynamics, Efficacy and Safety of Sodium-Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus 2015 8 134 93%
Biology of Human Sodium Glucose Transporters 2011 176 221 61%
SGLT2 inhibition - a novel strategy for diabetes treatment 2010 130 27 85%
Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes A Systematic Review and Meta-analysis 2013 73 35 80%
Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors 2014 17 34 94%
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2 2014 19 25 80%
Renal Na+-glucose cotransporters 2001 278 66 65%
SGLT2 inhibitors in the treatment of type 2 diabetes 2014 16 88 76%
Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target 2010 79 62 76%
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus 2010 75 46 78%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TIANJIN MOL DESIGN DRUG DISCOVERY 7 27% 2.0% 23
2 PROD PLANNING COORDINAT 6 71% 0.4% 5
3 EPITHELIAL CELL PHYSIOL 6 50% 0.7% 8
4 DRUG RAT 5 55% 0.5% 6
5 GEPROM 2 29% 0.6% 7
6 OBES ENDOCRINOL 2 15% 1.2% 14
7 RADIOL ONCOL RADIAT SCI ROS 2 67% 0.2% 2
8 TRANSLAT DEV PHARMACOL EUROPE 2 67% 0.2% 2
9 GLOBAL BIOMETR SCI 2 16% 1.0% 12
10 ENVIRONM BIOCHEM TOXICOL 2 25% 0.6% 7

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000139789 ATLANTIC WHITE SHRIMP//RAPID FILTRATION TECHNIQUE//NADC1
2 0.0000123676 FANCONI BICKEL SYNDROME//GLYCOGEN STORAGE DISEASE TYPE XI//GLUT2 GENE
3 0.0000092075 BIOL PROF E CAVIEDES CODELIA//GLUT5//MULTIDISCIPLINARIO INVEST BIOL SAN LUIS
4 0.0000064931 DPP 4 INHIBITOR//SITAGLIPTIN//VILDAGLIPTIN
5 0.0000061996 INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30
6 0.0000050025 SLC6//KAAT1//MOL NEUROPHARMACOL GRP
7 0.0000043085 LACTOSE PERMEASE//PHYSIOL MICROBIOL//MELIBIOSE CARRIER
8 0.0000039419 MITOCHONDRIAL OXIDATIVE ENZYMES//INSERM U319//RENAL CULTURED CELLS
9 0.0000038325 GLUCOSE TRANSPORTER//GLUT4//GLUT1
10 0.0000036811 RUBOXISTAURIN//PENN MOL STUDIES KIDNEY DIS//BEETHAM EYE OPHTHALMOL